Search research articles
Contact Us
Filters
Showing results (471-480 of 526) with videos related to
Page
of 53
Sort By:
International Journal of Molecular Sciences
|
February 24, 2024
A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody-Drug Conjugates
Nadine Barron, Stephan Dickgiesser, Markus Fleischer, et al.
Nature Communications
|
November 28, 2024
CLSY docking to Pol IV requires a conserved domain critical for small RNA biogenesis and transposon silencing
Luisa Felgines, Bart Rymen, Laura M Martins, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 7, 2026
GPRASP1 deletion suppresses antinociceptive tolerance during chronic activation of delta opioid receptor in persistent pain
Juliette Kaeffer, Marie-Laure Straub, Glenn-Marie Le Coz, et al.
Science Advances
|
February 18, 2026
Tuning of the RBR1-E2F/DP transcriptional module by the F-box protein FBL17
Juliette Espanet, Xiaoning He, Ting Pan, et al.
Nature Communications
|
June 12, 2021
E2F6 initiates stable epigenetic silencing of germline genes during embryonic development
Thomas Dahlet, Matthias Truss, Ute Frede, et al.
Oncogene
|
November 8, 2016
HSP110 promotes colorectal cancer growth through STAT3 activation
K Berthenet, A'dem Bokhari, A Lagrange, et al.
Nature Communications
|
October 23, 2024
Dominant immune tolerance in the intestinal tract imposed by RelB-dependent migratory dendritic cells regulates protective type 2 immunity
Anna-Lena Geiselhöringer, Daphne Kolland, Arisha Johanna Patt, et al.
Journal of the National Cancer Institute
|
November 25, 2015
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
Jessica Gobbo, Guillaume Marcion, Marine Cordonnier, et al.
Trials
|
June 10, 2020
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
Carlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, et al.
Cancer Research
|
November 17, 2007
Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis
Carmen Segrelles, Jerry Lu, Brian Hammann, et al.
Page
of 53
Search research articles
Search
Showing results (471-480 of 526) with videos related to
Sort By:
Page
of 53
International Journal of Molecular Sciences
|
February 24, 2024
A Generic Approach for Miniaturized Unbiased High-Throughput Screens of Bispecific Antibodies and Biparatopic Antibody-Drug Conjugates
Nadine Barron, Stephan Dickgiesser, Markus Fleischer, et al.
Nature Communications
|
November 28, 2024
CLSY docking to Pol IV requires a conserved domain critical for small RNA biogenesis and transposon silencing
Luisa Felgines, Bart Rymen, Laura M Martins, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 7, 2026
GPRASP1 deletion suppresses antinociceptive tolerance during chronic activation of delta opioid receptor in persistent pain
Juliette Kaeffer, Marie-Laure Straub, Glenn-Marie Le Coz, et al.
Science Advances
|
February 18, 2026
Tuning of the RBR1-E2F/DP transcriptional module by the F-box protein FBL17
Juliette Espanet, Xiaoning He, Ting Pan, et al.
Nature Communications
|
June 12, 2021
E2F6 initiates stable epigenetic silencing of germline genes during embryonic development
Thomas Dahlet, Matthias Truss, Ute Frede, et al.
Oncogene
|
November 8, 2016
HSP110 promotes colorectal cancer growth through STAT3 activation
K Berthenet, A'dem Bokhari, A Lagrange, et al.
Nature Communications
|
October 23, 2024
Dominant immune tolerance in the intestinal tract imposed by RelB-dependent migratory dendritic cells regulates protective type 2 immunity
Anna-Lena Geiselhöringer, Daphne Kolland, Arisha Johanna Patt, et al.
Journal of the National Cancer Institute
|
November 25, 2015
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer
Jessica Gobbo, Guillaume Marcion, Marine Cordonnier, et al.
Trials
|
June 10, 2020
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial
Carlos Chaccour, Paula Ruiz-Castillo, Mary-Ann Richardson, et al.
Cancer Research
|
November 17, 2007
Deregulated activity of Akt in epithelial basal cells induces spontaneous tumors and heightened sensitivity to skin carcinogenesis
Carmen Segrelles, Jerry Lu, Brian Hammann, et al.
Page
of 53